agitg trial news

AGITG Trial News

AGITG Trial news: The AGITG currently has ten studies open to recruitment and six studies in follow up.

The table below details the AGITG trials that are currently accruing patients.

Recruited Target Recruitment Period (months) Date of First Site Open (ANZ) Number of Sites Open 
DYNAMIC-III (Colon cancer) 607 1000 54 09 October 2017 42
DYNAMIC-Pancreas (Pancreatic cancer) 92 438 54 01 March 2019 26
DYNAMIC-Rectal (Rectal cancer) 248 408 36 18 June 2018 37
FORECAST-1 (Colorectal cancer) 28 30 12 11 September 2020 4
GENESCREEN 5-FU (Pan Tumour) 26 50 50 1 February 2021 2
INTEGRATE IIb (Gastro-oesophageal cancer) 40 450 24 28 April 2021 19
LICPIC (Colorectal cancer) 54 100 110 11 September 2018 2
MASTERPLAN (Pancreatic cancer) 16 120 48 01 October 2019 9
NABNEC (Neuroendocrine tumours) 55 58 54 15 September 2016 18
OXTOX (Colorectal cancer) 4 100 18 18 December 2020 5
PALEO (Oesophageal cancer) 5 54 36 16 September 2019 1
RANDOMS (Pancreatic cancer) 4 60 38 14 December 2020 3
RENO (Rectal cancer) 44 125 36 21 January 2019 7
RoLaCaRT-1  (Colorectal Cancer) 4 50 12 06 August 2021 6
SPAR (Rectal cancer) 91 222 48 13 April 2018 15

Recruitment figures are for Australian and New Zealand sites as at end September 2021.

Trial Results Lay Summaries (click on the links below): 
ABC
Adjuvant GIST/ EORTC 62024
AG0001H
AG9401
AG9801
ATTAX
ATTAX 2
Advanced GIST
AG9601
A La CaRT
ATTACHE
ATTAX-3
CO.17
CO.20
CO.23
DaVINCI
DECO
ESPAC-3
GAP
GOFURTGO
ICECREAM
IG9401
IMPACT
INTEGRATE
LAP07
MAGIC
MAX
NSABP CO6
NSABP CO-7
PA.3
PAN 1
PETACC-6
QUASAR 2
REGISTER
SCOT
TACTIC
TOP GEAR
TROG 01.04 / IG0103R

Share